Markus Dietlein

7PUBLICATIONS
7CO-AUTHORS
Reaction engineering (excl. nuclear reactions)Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyObstetrics and gynaecologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 28, 2026
Airborne Radioiodine: A Comparative View of Chemical Forms in Medicine, Nuclear Industry, and Fallout Scenarios.

Klaus Schomäcker, Ferdinand Sudbrock, Thomas Fischer

|Jul 12, 2025
Overcoming Multidrug Resistance Using DNA-Localized Auger Emitters: A Comparative Analysis of Radiotoxicity in Breast Cancer Cells.

Klaus Schomäcker, Beate Zimmermanns, Thomas Fischer

|Apr 29, 2025
Radioiodine Exhalation Following Oral I-131 Administration in a Mouse Model.

Klaus Schomäcker, Thomas Fischer, Ferdinand Sudbrock

|Mar 17, 2025
Radioiodine Therapy of Graves' Disease in Women with Childbearing Potential and the Pre-Conceptional Counseling About Antithyroid Drugs.

Markus Dietlein, Matthias Schmidt, Alexander Drzezga

|Oct 16, 2024
Tumoricidal Activity and Side Effects of Radiolabeled Anti-NCAM [<sup>131</sup>I]-Iodine-ERIC1 in Neuroblastoma-Bearing Mice.

Thomas Fischer, Felix Dietlein, Detlev Bongartz

|Oct 16, 2024
Localization and Tumor Growth Inhibition of I-131-Labeled Monoclonal Antibody ERIC1 in a Subcutaneous Xenograft Model of Small Cell Lung Cancer in SCID Mice.

Thomas Fischer, Christopher Dietrich, Felix Dietlein

Pageof 2